Skip to content
ProPublica Donate
ProPublica Donate

Als Therapy Development Foundation Inc

Heywood James

Organization summary

Type of Nonprofit

Designated as a Organizations for any of the following purposes: religious, educational, charitable, scientific, literary, testing for public safety, fostering national or international amateur sports competition (as long as it doesn't provide athletic facilities or equipment), or the prevention of cruelty to children or animals.

Category: Medical Research / Specifically Named Diseases Research (NTEE)

Donations to this organization are tax deductible.

Details

According to its Dec. 2023 tax filing, this nonprofit:

Reported conflict of interest transactions
Organizations must report loans, grants or business transactions with interested parties, which may include key employees and officers, their family members and any businesses in which they hold a controlling interest. These transactions must be reported on Schedule L.

Summary charts: organization finances over time

Revenue
$11.6M (2023)

Expenses
$11.2M (2023)

Total Assets
$20M (2023)

Total Liabilities
$5M (2023)

Source: Form 990 tax filings from 2011 to 2023

Tax Filings by Year

Form 990 is an information return that most organizations claiming federal tax-exempt status must file yearly with the IRS. Nonprofit Explorer has IRS digitized Form 990 data for filings processed in 2012 and later. If this organization filed an amended return, it may not be reflected below. Duplicate download links may indicate a resubmission or amendment to this organization's original return. Form 990 data is from the IRS.

Fiscal Year Ending Dec.
2023

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$11,558,482
Expenses
$11,160,593
Net Income
$397,889
Net Assets
$15,010,932
Notable Sources of Revenue Percent of Total Revenue
Contributions $10,029,574
86.8%
Program Services $657,980
5.7%
Investment Income $363,770
3.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $503,577
4.4%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $3,581
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $340,011
3.0%
Professional Fundraising Fees $27,160
0.2%
Other Salaries and Wages $3,753,298
33.6%
Assets/Debt
Total Assets $20,012,651
Total Liabilities $5,001,719
Net Assets $15,010,932
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Fernando Vieira (Ceo And Cso) $320,000 $0 $20,011
Alan Gill (Vp Of Research) $182,421 $0 $13,214
Carol Hamilton (Vp Of Development) $165,724 $0 $8,146
Theo Hatzipetros (Director Of Pharmacology) $150,899 $0 $20,236
Kyle R Denton (Director, Cell Biology) $150,194 $0 $8,434
Kenneth Thompson (Vp Of Facility Operation) $129,202 $0 $19,011
Lynne Nieto (Chairman (As Of 5/2023)) $0 $0 $0
Augie Nieto (Chairman (Until 2/2023)) $0 $0 $0
Steven Perrin Phd (Vice Chair) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
Paul Sallaberry (Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Julie Swan (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0
Andrew Niblock (Board Member) $0 $0 $0
Tom Engellenner (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2022

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$11,364,169
Expenses
$9,829,539
Net Income
$1,534,630
Net Assets
$15,228,481
Notable Sources of Revenue Percent of Total Revenue
Contributions $9,817,402
86.4%
Program Services $636,927
5.6%
Investment Income $66,813
0.6%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $739,865
6.5%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $103,162
0.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $330,812
3.4%
Professional Fundraising Fees $0
Other Salaries and Wages $3,354,892
34.1%
Assets/Debt
Total Assets $21,051,525
Total Liabilities $5,823,044
Net Assets $15,228,481
Compensation
Key Employees and Officers Compensation Related Other
Fernando Vieira (Ceo / Cso) $315,125 $0 $15,687
Alan Gill (Vp Of Research) $170,654 $0 $8,280
Matvey Lukashev (Vp Of Translation Sciences) $160,332 $0 $13,251
Carol Hamilton (Vp Of Development) $148,199 $0 $8,280
Kyle Denton (Director, Cell Biology) $134,069 $0 $20,622
Theo Hatzipetros (Director Of Pharmacology) $130,026 $0 $6,711
Augie Nieto (Chairman And Board Member) $0 $0 $0
Steven Perrin Phd (Vice Chair) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
Paul Sallaberry (Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Julie Swan (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0
Andrew Niblock (Board Member) $0 $0 $0
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Tom Engellenner (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2021

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$12,370,651
Expenses
$8,987,486
Net Income
$3,383,165
Net Assets
$16,521,762
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,401,098
92.2%
Program Services $628,036
5.1%
Investment Income $8,195
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $329,528
2.7%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $3,794
0.0%
Notable Expenses Percent of Total Expenses
Executive Compensation $294,285
3.3%
Professional Fundraising Fees $0
Other Salaries and Wages $3,057,364
34.0%
Assets/Debt
Total Assets $19,047,011
Total Liabilities $2,525,249
Net Assets $16,521,762
Compensation
Key Employees and Officers Compensation Related Other
Fernando Vieira (Ceo / Cso) $274,971 $0 $19,314
Bashar Al Nakhala (Chief Operating Officer) $194,993 $0 $20,173
Matvey Lukashev (Vp Of Translation Sciences) $173,583 $0 $7,159
Alan Gill (Vp Of Research) $170,347 $0 $12,244
Theo Hatzipetros (Director Of Pharmacology) $121,058 $0 $19,314
Kenneth Thompson (Director Of Lab) $116,998 $0 $16,166
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
Paul Sallaberry (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Julie Swan (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0
Andrew Niblock (Board Member) $0 $0 $0
Steven Perrin Phd (Vice Chair) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2020

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$10,248,613
Expenses
$9,529,307
Net Income
$719,306
Net Assets
$27,204,165
Notable Sources of Revenue Percent of Total Revenue
Contributions $8,062,216
78.7%
Program Services $265,315
2.6%
Investment Income $17,725
0.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $712,398
7.0%
Sales of Assets $1,100,942
10.7%
Net Inventory Sales $0
Other Revenue $90,017
0.9%
Notable Expenses Percent of Total Expenses
Executive Compensation $0
Professional Fundraising Fees $0
Other Salaries and Wages $3,540,039
37.1%
Assets/Debt
Total Assets $29,996,989
Total Liabilities $2,792,824
Net Assets $27,204,165
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Fernando Vieira (Chief Scientific Officer) $243,145 $0 $19,220
Bashar Al Nakhala (Chief Operating Officer) $200,994 $0 $20,220
Alan Gill (Vp Of Research) $176,211 $0 $13,229
Matvey Lukashev (Vp Of Translational Sciences) $174,637 $0 $6,813
Theo Hatzipetros (Director Of Pharmacology) $121,047 $0 $20,220
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Board Member) $0 $0 $0
Rob Rodin (Chairman And Board Member) $0 $0 $0
Steven Perrin Phd (Ceo/President And Secretary) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Julie Swan (Board Member) $0 $0 $0
Eric S Craven (Board Member (Until 4/2020)) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0
Andrew Niblock (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2019

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$13,129,736
Expenses
$11,458,890
Net Income
$1,670,846
Net Assets
$15,090,130
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,823,260
90.0%
Program Services $410,883
3.1%
Investment Income $50,014
0.4%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $565,943
4.3%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $279,636
2.1%
Notable Expenses Percent of Total Expenses
Executive Compensation $205,627
1.8%
Professional Fundraising Fees $253,000
2.2%
Other Salaries and Wages $3,788,900
33.1%
Assets/Debt
Total Assets $17,469,547
Total Liabilities $2,379,417
Net Assets $15,090,130
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Fernando Vieira (Chief Scientific Officer) $216,335 $0 $19,020
Steven Perrin Phd (Ceo/President And Vice Chairman) $195,904 $0 $9,723
Bashar Al Nakhala (Chief Operating Officer) $169,448 $0 $20,020
Alan Gill (Vp Of Research And Develop) $168,771 $0 $13,221
Matvey Lukashev (Sr. Director Of Translatio) $160,724 $0 $6,743
Theo Hatzipetros (Director Of Pharmacology) $115,949 $0 $20,020
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Julie Swan (Board Member) $0 $0 $0
Eric S Craven (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0
Andrew Niblock (Board Member) $0 $0 $0
Paul Sallaberry (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2018

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$15,038,596
Expenses
$12,329,559
Net Income
$2,709,037
Net Assets
$13,419,284
Notable Sources of Revenue Percent of Total Revenue
Contributions $12,729,824
84.6%
Program Services $1,175,932
7.8%
Investment Income $34,605
0.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $701,332
4.7%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $396,903
2.6%
Notable Expenses Percent of Total Expenses
Executive Compensation $385,598
3.1%
Professional Fundraising Fees $0
Other Salaries and Wages $4,254,532
34.5%
Assets/Debt
Total Assets $15,652,260
Total Liabilities $2,232,976
Net Assets $13,419,284
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Steven Perrin Phd (Ceo/President) $366,268 $0 $19,330
Shannon Shryne (Vp Of Strategic Partnership) $191,850 $0 $13,789
Fernando Vieira (Chief Scientific Officer) $173,343 $0 $18,330
Alan Gill (Vp Of Research And Develop) $168,784 $0 $13,170
Matvey Lukashev (Sr. Director Of Translational) $160,548 $0 $6,497
Gretchen Simoneaux (Sr. Development Director) $148,111 $0 $20,057
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Julie Swan (Board Member) $0 $0 $0
Eric S Craven (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0
Andrew Niblock (Board Member) $0 $0 $0
Paul Sallaberry (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2017

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$17,248,520
Expenses
$12,533,202
Net Income
$4,715,318
Net Assets
$10,710,247
Notable Sources of Revenue Percent of Total Revenue
Contributions $14,163,205
82.1%
Program Services $1,374,412
8.0%
Investment Income $9,636
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $1,409,260
8.2%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $292,007
1.7%
Notable Expenses Percent of Total Expenses
Executive Compensation $362,120
2.9%
Professional Fundraising Fees $0
Other Salaries and Wages $3,962,373
31.6%
Assets/Debt
Total Assets $13,595,583
Total Liabilities $2,885,336
Net Assets $10,710,247
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Steven Perrin Phd (Ceo/Cso/Pres., Vice Chairm) $343,462 $0 $18,658
Alan Gill (Vp Of Research And Develop) $158,502 $0 $13,123
Fernando Vieira (Director Of Research) $150,320 $0 $18,658
Matvey Lukashev (Director Of Translational) $150,053 $0 $7,259
Shannon Shyrne (Vp Of Development) $127,468 $0 $12,649
Robert Goldstein (Vp Of Marketing, Communication & Dev.) $124,687 $0 $6,640
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Cheryl Smith (Board Member) $0 $0 $0
Eric S Craven (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2016

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$11,833,820
Expenses
$11,268,335
Net Income
$565,485
Net Assets
$5,994,929
Notable Sources of Revenue Percent of Total Revenue
Contributions $10,283,977
86.9%
Program Services $978,779
8.3%
Investment Income $6,115
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $185,963
1.6%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $378,986
3.2%
Notable Expenses Percent of Total Expenses
Executive Compensation $367,834
3.3%
Professional Fundraising Fees $0
Other Salaries and Wages $3,908,601
34.7%
Assets/Debt
Total Assets $9,084,217
Total Liabilities $3,089,288
Net Assets $5,994,929
Other
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Steven Perrin Phd (Ceo/Cso/Pres., Vice Chairm) $349,558 $0 $18,276
Alan Gill (Vp Of Research And Development) $149,571 $0 $16,468
Matvey Lukashev (Director Of Translational Research) $146,854 $0 $6,067
Fernando Vieira (Director Of Research) $135,968 $0 $18,276
Shannon Shyrne (Vp Of Development) $127,059 $0 $11,929
Robert Goldstein (Vp Of Marketing, Communication & Develoopment) $124,730 $0 $6,469
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Cheryl Smith (Board Member) $0 $0 $0
Eric S Craven (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2015

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$9,400,531
Expenses
$12,678,315
Net Income
-$3,277,784
Net Assets
$5,429,444
Notable Sources of Revenue Percent of Total Revenue
Contributions $7,743,559
82.4%
Program Services $293,663
3.1%
Investment Income $9,003
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $1,213,175
12.9%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $141,131
1.5%
Notable Expenses Percent of Total Expenses
Executive Compensation $367,404
2.9%
Professional Fundraising Fees $0
Other Salaries and Wages $4,234,924
33.4%
Assets/Debt
Total Assets $8,357,864
Total Liabilities $2,928,420
Net Assets $5,429,444
Other
Provided first-class or charter travel
Reported conflict of interest transactions
Compensation
Key Employees and Officers Compensation Related Other
Steven Perrin Phd (Ceo/Cso/Pres., Vice Chairm) $350,335 $0 $17,069
Alan Gill (Vp Of Research And Development) $150,347 $0 $17,069
Matvey Lukashev (Director Of Translational Research) $147,108 $0 $5,921
Fernando Vieira (Director Of Research) $135,745 $0 $16,569
Shannon Shyrne (Vp Of Development) $125,813 $0 $14,030
Robert Goldstein (Vp Of Marketing, Communications & Development) $124,520 $0 $6,434
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Cheryl Smith (Board Member) $0 $0 $0
Eric S Craven (Board Member) $0 $0 $0
Kent Jackson Bransford Md (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2014

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$14,319,785
Expenses
$11,489,410
Net Income
$2,830,375
Net Assets
$8,707,228
Notable Sources of Revenue Percent of Total Revenue
Contributions $13,405,432
93.6%
Program Services $435,914
3.0%
Investment Income $5,151
0.0%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $473,288
3.3%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $386,765
3.4%
Professional Fundraising Fees $0
Other Salaries and Wages $4,004,755
34.9%
Assets/Debt
Total Assets $11,349,070
Total Liabilities $2,641,842
Net Assets $8,707,228
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Steven Perrin Phd (Ceo/Cso/Pres., Vice Chairm) $366,864 $0 $19,902
Alan Gill (Vp Research And Developmen) $184,878 $0 $19,750
Matvey Lukashev (Director, Translational Research) $162,280 $0 $7,974
John Lincecum (Director Of Discovery Biol) $159,381 $0 $18,119
Fernando Vieira (Dir. Of Research) $153,076 $0 $19,800
Robert Goldstein (Vp Of Marketing, Communications & Development) $136,675 $0 $7,428
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Dr Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0
Lynne Nieto (Board Member) $0 $0 $0
Steven Fowler (Board Member Resigned During 2014) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2013

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$8,800,851
Expenses
$9,532,874
Net Income
-$732,023
Net Assets
$5,876,853
Notable Sources of Revenue Percent of Total Revenue
Contributions $8,115,487
92.2%
Program Services $408,977
4.6%
Investment Income $5,924
0.1%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $270,463
3.1%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $384,116
4.0%
Professional Fundraising Fees $0
Other Salaries and Wages $3,391,391
35.6%
Assets/Debt
Total Assets $6,746,369
Total Liabilities $869,516
Net Assets $5,876,853
Other
Provided first-class or charter travel
Compensation
Key Employees and Officers Compensation Related Other
Steven Perrin Phd (Ceo/Cso/Pres., Vice Chairman) $365,317 $0 $18,799
Alan Gill (Vp Research And Development) $159,351 $0 $18,550
John Lincecum (Director Of Discovery Biology) $140,667 $0 $17,979
Fernando Vieira (Dir. Of Research) $139,326 $0 $18,597
Bashar Al Nakhala (Vice President It) $117,235 $0 $18,546
Patricia Tanski (Former Vp Of Development) $114,503 $0 $1,387
Vladimir Morozov (Senior Scientist) $112,230 $0 $16,929
Dr Stanley H Appel Md (Board Member) $0 $0 $0
Alexander Cappello (Board Member) $0 $0 $0
Spiros Jamas Scd (Board Member) $0 $0 $0
Keith Melanson (Board Member) $0 $0 $0
Leslie Michelson Jd (Board Member) $0 $0 $0
John B Heywood Phd Scd (Board Member) $0 $0 $0
Augie Nieto (Chairman And Board Member) $0 $0 $0
Rob Rodin (Board Member) $0 $0 $0
James Allen Heywood (Board Member) $0 $0 $0
Theodore Reich Jd Cpa (Treasurer And Board Member) $0 $0 $0
John Sutherland (Secretary And Board Member) $0 $0 $0
Steven Fowler (Board Member) $0 $0 $0
Robert Sepucha (Board Member) $0 $0 $0
Jenny Dwyer (Board Member) $0 $0 $0
Mike Smith (Board Member) $0 $0 $0

Document Links

Fiscal Year Ending Dec.
2012

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$11,569,062
Expenses
$9,706,227
Net Income
$1,862,835
Net Assets
$6,608,876
Notable Sources of Revenue Percent of Total Revenue
Contributions $11,018,319
95.2%
Program Services $273,960
2.4%
Investment Income $70,907
0.6%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $205,876
1.8%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $402,033
4.1%
Professional Fundraising Fees $0
Other Salaries and Wages $3,369,977
34.7%
Assets/Debt
Total Assets $7,256,370
Total Liabilities $647,494
Net Assets $6,608,876

Document Links

Fiscal Year Ending Dec.
2011

Extracted Financial Data

Extracted Financial Data from Form 990
Revenue
$7,985,542
Expenses
$7,731,079
Net Income
$254,463
Net Assets
$4,746,041
Notable Sources of Revenue Percent of Total Revenue
Contributions $6,444,164
80.7%
Program Services $743,150
9.3%
Investment Income $15,882
0.2%
Bond Proceeds $0
Royalties $0
Rental Property Income $0
Net Fundraising $782,346
9.8%
Sales of Assets $0
Net Inventory Sales $0
Other Revenue $0
Notable Expenses Percent of Total Expenses
Executive Compensation $388,403
5.0%
Professional Fundraising Fees $0
Other Salaries and Wages $2,709,250
35.0%
Assets/Debt
Total Assets $5,421,510
Total Liabilities $675,469
Net Assets $4,746,041

Document Links

Fiscal Year Ending Dec.
2010

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2009

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2008

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2007

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2006

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2005

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2004

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

Fiscal Year Ending Dec.
2003

No Extracted Financial Data

Extracted financial data is not available for the forms filed in this tax period, but Form 990 documents are available for download.

Document Links

About This Data

Nonprofit Explorer includes summary data for nonprofit tax returns and full Form 990 documents, in both PDF and digital formats.

The summary data contains information processed by the IRS during the 2012-2019 calendar years; this generally consists of filings for the 2011-2018 fiscal years, but may include older records. This data release includes only a subset of what can be found in the full Form 990s.

In addition to the raw summary data, we link to PDFs and digital copies of full Form 990 documents wherever possible. This consists of separate releases by the IRS of Form 990 documents processed by the agency, which we update regularly.

We also link to copies of audits nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year since 2016. These audits are copied from the Federal Audit Clearinghouse.

Which Organizations Are Here?

Every organization that has been recognized as tax exempt by the IRS has to file Form 990 every year, unless they make less than $200,000 in revenue and have less than $500,000 in assets, in which case they have to file form 990-EZ. Organizations making less than $50,000 don’t have to file either form but do have to let the IRS they’re still in business via a Form 990N "e-Postcard."

Nonprofit Explorer has organizations claiming tax exemption in each of the 27 subsections of the 501(c) section of the tax code, and which have filed a Form 990, Form 990EZ or Form 990PF. Taxable trusts and private foundations that are required to file a form 990PF are also included. Small organizations filing a Form 990N "e-Postcard" are not included in this data.

Types of Nonprofits

There are 27 nonprofit designations based on the numbered subsections of section 501(c) of the tax code. See the list »

Get the Data

For those interested in acquiring the original data from the source, here’s where our data comes from:

  • Raw filing data. Includes EINs and summary financials as structured data.
  • Exempt Organization profiles. Includes organization names, addresses, etc. You can merge this with the raw filing data using EIN numbers.
  • Form 990 documents. Prior to 2017, these documents were obtained and processed by Public.Resource.org and ProPublica. Bulk PDF downloads since 2017 are available from the IRS.
  • Form 990 documents as XML files. Includes complete filing data (financial details, names of officers, tax schedules, etc.) in machine-readable format. Only available for electronically filed documents. Electronic data released prior to October 2021 is also available through Amazon Web Services.
  • Audits. PDFs of single or program-specific audits for nonprofit organizations that spent $750,000 or more in Federal grant money in a single fiscal year. Available for fiscal year 2015 and later.

API

The data powering this website is available programmatically, via an API. Read the API documentation »